Publications by authors named "Javier Maynar"

Claim this Profile
C
Contact Aspiration Alone or Combined With Stent Retriever Thrombectomy for Middle Cerebral Artery Large Vessel Occlusion.
Pedro Navia, Andres Fernandez-Prieto, Alberto Alvarez-Muelas, Ángel Calleja, Joaquin Ortega, Javier Maynar

J Neuroimaging· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Ceftaroline and Avibactam Removal by Continuous Renal Replacement Therapies: An in vitro Study.
Ana Alarcia-Lacalle, Helena Barrasa, Javier Maynar, Andrés Canut-Blasco, María Ángeles Solinís

Blood Purif· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimization of levetiracetam dosing regimen in critically ill patients with augmented renal clearance: a Monte Carlo simulation study.
Idoia Bilbao-Meseguer, Helena Barrasa, Alicia Rodríguez-Gascón, Eduardo Asín-Prieto, Javier Maynar

J Intensive Care· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population Pharmacokinetics of Levetiracetam and Dosing Evaluation in Critically Ill Patients with Normal or Augmented Renal Function.
Idoia Bilbao-Meseguer, Helena Barrasa, Eduardo Asín-Prieto, Ana Alarcia-Lacalle, Alicia Rodríguez-Gascón, Javier Maynar

Pharmaceutics· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantification of Ceftaroline in Human Plasma Using High-Performance Liquid Chromatography with Ultraviolet Detection: Application to Pharmacokinetic Studies.
Ana Alarcia-Lacalle, Helena Barrasa, Javier Maynar, Andrés Canut-Blasco, Carmen Gómez-González

Pharmaceutics· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High rate of infections during ICU admission of patients with severe SARS-CoV-2 pneumonia: A matter of time?
Helena Barrasa, Alejandro Martín, Javier Maynar, Jordi Rello, Marina Fernández-Torres

J Infect· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-CoV-2 in Spanish Intensive Care Units: Early experience with 15-day survival in Vitoria.
Helena Barrasa, Jordi Rello, Sofia Tejada, Alejandro Martín, Goiatz Balziskueta, Javier Maynar

Anaesth Crit Care Pain Med· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of augmented renal clearance on the pharmacokinetics of linezolid: Advantages of continuous infusion from a pharmacokinetic/pharmacodynamic perspective.
Helena Barrasa, Amaia Soraluce, Elena Usón, Javier Sainz, Alejandro Martín, Javier Maynar

Int J Infect Dis· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel Population Pharmacokinetic Model for Linezolid in Critically Ill Patients and Evaluation of the Adequacy of the Current Dosing Recommendation.
Amaia Soraluce, Helena Barrasa, Eduardo Asín-Prieto, Jose Ángel Sánchez-Izquierdo, Javier Maynar

Pharmaceutics· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ACUsmart Continuous Renal Replacement Therapy Platform: Multicenter Pilot Study for Technical and Clinical Assessment (A.M.P. Study).
Mauro Neri, Anna Lorenzin, Massimo de Cal, Alessandra Brendolan, Nicola Marchionna, Javier Maynar

Blood Purif· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of linezolid in critically ill patients on continuous renal replacement therapy: Influence of residual renal function on PK/PD target attainment.
Helena Barrasa, Amaia Soraluce, Arantxazu Isla, Alejandro Martín, Javier Maynar

J Crit Care· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanical thrombectomy in patients with tumour-related ischaemic stroke.
Tobias Zander, Javier Maynar, Fernando López-Zárraga, Rogelio Herrera, Juan José Timiraos-Fernández, Manuel Maynar

Interv Neuroradiol· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population pharmacokinetics of piperacillin and tazobactam in critically ill patients undergoing continuous renal replacement therapy: application to pharmacokinetic/pharmacodynamic analysis.
Eduardo Asín-Prieto, Alicia Rodríguez-Gascón, Iñaki F Trocóniz, Amaia Soraluce, Javier Maynar

J Antimicrob Chemother· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Direct hemoperfusion with polymyxin B-immobilized cartridge in severe sepsis due to intestinal perforation: hemodynamic findings and clinical considerations in anticoagulation therapy.
Javier Maynar, Fernando Martínez-Sagasti, Manuel Herrera-Gutiérrez, Francisco Martí, Francisco Javier Candel

Rev Esp Quimioter· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population pharmacokinetics of meropenem in critically ill patients undergoing continuous renal replacement therapy.
Arantxazu Isla, Alicia Rodríguez-Gascón, Iñaki F Trocóniz, Lorea Bueno, María Angeles Solinís, Javier Maynar

Clin Pharmacokinet· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro AN69 and polysulphone membrane permeability to ceftazidime and in vivo pharmacokinetics during continuous renal replacement therapies.
Arantxazu Isla, Alicia R Gascón, Javier Maynar, Alazne Arzuaga, José Antonio Sánchez-Izquierdo

Chemotherapy· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Meropenem and continuous renal replacement therapy: in vitro permeability of 2 continuous renal replacement therapy membranes and influence of patient renal function on the pharmacokinetics in critically ill patients.
Arantxazu Isla, Javier Maynar, José Angel Sánchez-Izquierdo, Alicia R Gascón, Alazne Arzuaga

J Clin Pharmacol· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro and in vivo evaluation of enoxaparin removal by continuous renal replacement therapies with acrylonitrile and polysulfone membranes.
Arantxazu Isla, Alicia R Gascón, Javier Maynar, Alazne Arzuaga, Esther Corral

Clin Ther· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Study protocol: the DOse REsponse Multicentre International collaborative initiative (DO-RE-MI).
Detlef Kindgen-Milles, Didier Journois, Roberto Fumagalli, Sergio Vesconi, Javier Maynar

Crit Care· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cefepime and continuous renal replacement therapy (CRRT): in vitro permeability of two CRRT membranes and pharmacokinetics in four critically ill patients.
Arantxazu Isla, Alicia Rodríguez Gascón, Javier Maynar, Alazne Arzuaga, Darío Toral

Clin Ther· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of renal function on the pharmacokinetics of piperacillin/tazobactam in intensive care unit patients during continuous venovenous hemofiltration.
Alazne Arzuaga, Javier Maynar, Alicia R Gascón, Arantxazu Isla, Esther Corral

J Clin Pharmacol· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis